Fresenius Medical Care AG & Co. KGaA · FMS · Next earnings

Fresenius Medical Care AG & Co. KGaA reports Tuesday, Nov 3, 2026

FMS reports before market open with consensus EPS at $0.65 and revenue at $5.52B. Last quarter: Fresenius Medical Care cuts 2026 outlook as cost and reimbursement pressure persist

Reports Before market open0 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $0.65 Calendar consensus
Consensus revenue $5.52B Calendar consensus
Report date Nov 3, 2026 Tuesday, date estimated
Session Before market open 0 days away

Where FMS left off: FY2026 Q3

Full report

Fresenius Medical Care cuts 2026 outlook as cost and reimbursement pressure persist

EPS surprise — Reported — vs $0.65
Revenue surprise — Reported — vs $5.52B
Stock move -3.6% Event window
Subsequent drift 0.0% Up to 20 sessions

2026 operating-income guidance was lowered to flat-to-negative mid-single-digit growth. The supplied prior-quarter analysis says guidance had been maintained.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • TDAPA reimbursement headwinds are expected to increase in Q4 2026 and 2027.
  • Raw-material, logistics and labor inflation could exceed expectations.
  • Stagnating U.S. patient inflows and referral dynamics could constrain volume.
  • Recent FDA audit findings require remediation; China volume and pricing pressures also remain.

Questions analysts left open

  • How large and persistent will TDAPA headwinds be through 2027?
  • Can cost reduction be balanced with reinvestment for growth?
  • What are the trends in U.S. patient inflows and referrals, and how will DaVita’s MCO transition affect Care Enablement revenue?

Ask FN2 about FMS next report

Transcript, numbers and history already loaded
What should I watch for in FMS's next earnings report?How did FMS guide last quarter, and is consensus above or below that?Give me the bull and bear case going into FMS earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the FMS recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent FMS quarters

All FMS earnings
-3.6%FY2026 Q3

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.